Results 11 to 20 of about 17,684 (152)

Riboflavin transporter deficiency, the search for the undiagnosed: a retrospective data mining study [PDF]

open access: yesOrphanet Journal of Rare Diseases
Background Riboflavin transporter deficiency (RTD) is an inborn error of riboflavin transport causing progressive neurological symptoms if left untreated.
B. Jaeger   +5 more
doaj   +8 more sources

A riboflavin transporter deficiency presenting as pure red cell aplasia: a pediatric case report [PDF]

open access: yesFrontiers in Pediatrics
IntroductionRiboflavin transporter deficiency (RTD) is a rare genetic disorder that affects riboflavin transport, leading to impaired red blood cell production and resulting in pure red cell aplasia.
Jingying Cheng   +5 more
doaj   +5 more sources

Caspase-dependent apoptosis in Riboflavin Transporter Deficiency iPSCs and derived motor neurons [PDF]

open access: yesCell Death Discovery, 2023
Riboflavin Transporter Deficiency (RTD) is a rare genetic, childhood-onset disease. This pathology has a relevant neurological involvement, being characterized by motor symptoms, ponto-bulbar paralysis and sensorineural deafness.
Chiara Marioli   +9 more
doaj   +8 more sources

Role of Otolaryngologists in the Treatment of Patients With Riboflavin Transporter Deficiency: A Case Report. [PDF]

open access: yesCureus, 2023
Riboflavin transporter deficiency (RTD) is a rare genetic disorder that can have detrimental effects on the nervous system, causing progressive neurodegeneration. Here, we report the second case of RTD in Saudi Arabia.
Alasqah MI   +4 more
europepmc   +4 more sources

Long-term outcomes in children with riboflavin transporter deficiency and surveillance recommendations. [PDF]

open access: yesDev Med Child Neurol
The aim of this longitudinal case series was to describe long‐term functional outcome in a group of individuals with riboflavin transporter deficiency (RTD) treated with high‐dose oral riboflavin. Data were collected between 2012 to 2022.
Fennessy JR   +5 more
europepmc   +7 more sources

Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency

open access: yesJournal of the Peripheral Nervous System, 2023
Riboflavin transporter deficiency (RTD) is a progressive inherited neuropathy of childhood onset, characterised by pontobulbar palsy, sensorineural deafness, sensory ataxia, muscle weakness, optic atrophy and respiratory failure.
Jack R Fennessy   +2 more
exaly   +4 more sources

Mitochondrial and Peroxisomal Alterations Contribute to Energy Dysmetabolism in Riboflavin Transporter Deficiency. [PDF]

open access: yesOxid Med Cell Longev, 2020
Riboflavin transporter deficiency (RTD) is a childhood-onset neurodegenerative disorder characterized by progressive pontobulbar palsy, sensory and motor neuron degeneration, sensorineural hearing loss, and optic atrophy.
Colasuonno F   +9 more
europepmc   +5 more sources

Successful treatment of a genetic childhood ataxia due to riboflavin transporter deficiency. [PDF]

open access: yesCerebellum Ataxias, 2018
Riboflavin transporter deficiency (Brown-Vialetto-Van Laere syndrome) is a rare recessive neurodegenerative disorder that can present with gait ataxia, primarily due to sensory neuropathy as well as cerebellar involvement.
Fan J, Fogel BL.
europepmc   +5 more sources

Development of a functional outcome measure for riboflavin transporter deficiency

open access: yesJournal of the Peripheral Nervous System
Riboflavin transporter deficiency (RTD) is a progressive inherited neuropathy of childhood onset, characterised clinically by pontobulbar palsy, sensory ataxia, sensorineural deafness, muscle weakness, optic atrophy and respiratory failure.
Jack R Fennessy   +2 more
exaly   +4 more sources

An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency [PDF]

open access: yesJournal of Inherited Metabolic Disease, 2019
Riboflavin transporter deficiency (RTD) is a rare neurological condition that encompasses the Brown‐Vialetto‐Van Laere and Fazio‐Londe syndromes since the discovery of pathogenic mutations in the SLC52A2 and SLC52A3 genes that encode human riboflavin ...
Benjamin O'Callaghan   +2 more
exaly   +5 more sources

Home - About - Disclaimer - Privacy